KRYS MEXC RealStocks
Own real KRYS shares through MEXC's regulated brokerage partner.
Suitable for long-term holding.
- Own the actual shares
- Receive dividends and voting rights
- Buy fractional shares starting at $1
Last updated: 2026-11-19 02:28:20. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Krystal Biotech, Inc. (KRYS) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector and is listed on NASDAQ. The stock is currently priced at $315.09, with a market capitalization of $8.83B and a P/E ratio of 39.29. Over the past 52 weeks, its price has ranged from $202.99 to $382.54. This page covers its latest market performance, valuation, price trends and company information.
$8.83B | |
$297.60 | |
$320.61 | |
$297.54 | |
$298.55 | |
231.79K | |
283.31K | |
39.29 | |
$382.54 | |
$202.99 | |
-- | |
2026-09-30 |
Krystal Biotech, Inc. (KRYS) last closed at $315.09 as of 2026-11-19 00:31:00, up 5.60% ($16.71) from the previous close of $298.55.
During the latest regular trading session, KRYS traded between $297.54 and $320.61, with a volume of 231.79K shares. The closing price was near the upper end and near the middle of its 52-week range.
Over the past seven days, Krystal Biotech, Inc. (KRYS) moved from $303.06 to $315.09, representing a gain of 3.97% ($12.03).
The stock traded between $295.01 and $320.61 during the period. The latest price is near the upper end of the 7-day range, indicating moderate upward.
The average daily volume was 184.01 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 62.4%
KRYS is currently trading at $315.09, placing it 62.4% of the way from its 52-week low of $202.99 to its 52-week high of $382.54. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Krystal Biotech Inc is an integrated, commercial-stage biotechnology company focused on the discovery, development, manufacturing, and commercialization of genetic medicines to treat diseases with high unmet medical needs. The company uses its patented HSV-1-based gene therapy platform to create vectors that deliver therapeutic transgenes to target cells. It possesses exclusive rights to develop, manufacture, and commercialize VYJUVEK internationally. The company operates as one operating segment focused on pharmaceutical products and manufactures, markets, and sells VYJUVEK in the United States and markets and sells VYJUVEK in the European Union, and Japan.
| Industry | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) |
| Employees | 295 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Krystal Biotech, Inc. (KRYS) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to KRYS, including Stocks, Tokenized Stocks, and Stock Futures.
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Estimate the value between KRYS shares and USD.
KRYS Shares to USD
1.00 KRYS shares = 315.089 USD
Calculations are estimates based on the latest available price and are for reference only.